Sherbrooke Park Advisers’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,891
Closed -$452K 699
2024
Q4
$452K Buy
+4,891
New +$480K 0.14% 253
2024
Q1
Sell
-13,850
Closed -$924K 881
2023
Q4
$924K Buy
+13,850
New +$897K 0.43% 65
2023
Q3
Sell
-3,600
Closed -$244K 534
2023
Q2
$244K Sell
3,600
-1,800
-33% -$113K 0.13% 276
2023
Q1
$292K Buy
+5,400
New +$314K 0.44% 102

Other funds holding EHC

Sherbrooke Park Advisers's EHC Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 4,891 shares — an estimated $452K sold.

Sherbrooke Park Advisers first reported a position in EHC in Q1 2023 and held it in 4 quarters. The position peaked at $924K in Q4 2023. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 4,891 Encompass Health shares in Q1 2025, an estimated $452K.
  • Sherbrooke Park Advisers first reported a position in Encompass Health in Q1 2023 and held it in 4 quarters.
  • Sherbrooke Park Advisers's Encompass Health position peaked at $924K in Q4 2023.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.